Cannabis medicines provider Mamedica raises £4.5m led by Casa Verde and Bobby Zamora
This article covers a funding round on 16 September 2025 at Mamedica, a London-based provider of cannabis-based prescription medicines, founded by Jon Robson. The company raised £4.5m in a round led by Casa Verde with participation from Bobby Zamora.
What does Mamedica do?
Mamedica is a London-based service that provides cannabis medicines through remote specialist consultations and next-day home delivery. It is used to treat long-term and nerve-related conditions such as pain, anxiety, ADHD and depression.
Why is Mamedica useful?
Problem
Patients with chronic and neurological conditions need specialist cannabis-based prescription medicines for pain, anxiety, ADHD and depression. Access to remote specialist consultations and reliable nationwide medicine delivery can be limited or hard to arrange.
Solution
Mamedica helps by offering remote consultations with specialists for prescription cannabis-based medicines. They deliver medication nationwide via secure next-day courier, simplifying treatment and access.
How much did Mamedica raise?
Mamedica raised £4.5m in funding, led by Casa Verde alongside Premier League star Bobby Zamora and existing backers.
Who invested in Mamedica?
The key investors in the company include the following.
- Casa Verde: a venture capital firm focusing on cannabis and adjacent businesses, with a strong presence in the US.
- Bobby Zamora: an angel investor bringing expertise in professional sport and public engagement.
- Mark Noble: an angel investor with a background in elite football and community leadership.
- Members of the executive team at XTX Markets: angel investors experienced in financial markets and trading infrastructure.
- Jay Rutland: an angel investor specialising in strategic commercial partnerships within healthcare.
- Anthony Tabatznik: an angel investor known for his work in life sciences investments and pharma networks.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Who founded Mamedica?
Jon Robson is the CEO and founder of Mamedica.
Where is Mamedica based?
Mamedica is based in London, UK.
What sector is Mamedica in?
Mamedica operates in the cannabis-based prescription medicines sector. This sector develops and provides medicines made from cannabis for treating medical conditions. In plain terms, it offers prescribed cannabis products to help with pain, anxiety and other conditions.
Key trends and challenges in medical cannabis sector:
Regulatory inconsistency
National rules vary, causing unequal patient access and prescribing limits; the UK and Germany use different frameworks.
Limited high-quality clinical evidence
Large randomised trials remain limited, so doctors often rely on small studies; Epidiolex is approved for epilepsy.
Product quality and consistency
Product quality and dosing vary between suppliers, raising safety concerns; testing sometimes finds label mismatches.
For a deeper look at innovation in this space, see the healthtech startups in the UK.
They've invested in Mamedica
Get to know these healthtech investors
Click here for a full list of 7,526+ startup investors in the UK